Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy

With a minimum followup of 10 years, results are excellent and do not differ for LR or IR prostate cancer patients. HR patients are a very heterogeneous group, and excellent results can still be achieved for HR patients with only one HR feature.